Search research articles
Contact Us
Filters
Showing results (111-120 of 322) with videos related to
Page
of 33
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
December 18, 2020
Interim [<sup>18</sup>F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
Christos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, et al.
Cancers
|
October 23, 2021
Fractal and Multifractal Analysis of PET-CT Images for Therapy Assessment of Metastatic Melanoma Patients under PD-1 Inhibitors: A Feasibility Study
Anastasia Kosmou, Christos Sachpekidis, Leyun Pan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 14, 2017
Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the Literature
Julia K Winkler, Ralf Gutzmer, Carolin Bender, et al.
Cancers
|
December 23, 2022
Postoperative Radiotherapy and the Role of Regional Lymph Node Irradiation in Localized Merkel Cell Carcinoma: A Single-Center Retrospective Analysis
Lisa-Antonia Dinges, Tanja Eichkorn, Sebastian Regnery, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 11, 2017
Absolute number of new lesions on <sup>18</sup>F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab
Hoda Anwar, Christos Sachpekidis, Julia Winkler, et al.
Head & Neck
|
November 13, 2015
Raster-scanned intensity-controlled carbon ion therapy for mucosal melanoma of the paranasal sinus
Angela Mohr, Naved Chaudhri, Jessica C Hassel, et al.
Oncotarget
|
May 7, 2016
Which melanoma patient carries a BRAF-mutation? A comparison of predictive models
Thomas Eigentler, Zeinab Assi, Jessica C Hassel, et al.
International Journal of Cancer
|
November 21, 2022
Molecular prediction of clinical response to anti-PD-1/anti-PD-L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry-based investigations
Rémi Longuespée, Dirk Theile, Inka Zörnig, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 15, 2023
Can physiologic colonic [<sup>18</sup>F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
Christos Sachpekidis, Christoph K Stein-Thoeringer, Annette Kopp-Schneider, et al.
Trends in Immunology
|
December 28, 2024
Targeting molecular pathways to control immune checkpoint inhibitor toxicities
Robin Reschke, Ryan J Sullivan, Evan J Lipson, et al.
Page
of 33
Search research articles
Search
Showing results (111-120 of 322) with videos related to
Sort By:
Page
of 33
European Journal of Nuclear Medicine and Molecular Imaging
|
December 18, 2020
Interim [<sup>18</sup>F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
Christos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, et al.
Cancers
|
October 23, 2021
Fractal and Multifractal Analysis of PET-CT Images for Therapy Assessment of Metastatic Melanoma Patients under PD-1 Inhibitors: A Feasibility Study
Anastasia Kosmou, Christos Sachpekidis, Leyun Pan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 14, 2017
Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the Literature
Julia K Winkler, Ralf Gutzmer, Carolin Bender, et al.
Cancers
|
December 23, 2022
Postoperative Radiotherapy and the Role of Regional Lymph Node Irradiation in Localized Merkel Cell Carcinoma: A Single-Center Retrospective Analysis
Lisa-Antonia Dinges, Tanja Eichkorn, Sebastian Regnery, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 11, 2017
Absolute number of new lesions on <sup>18</sup>F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab
Hoda Anwar, Christos Sachpekidis, Julia Winkler, et al.
Head & Neck
|
November 13, 2015
Raster-scanned intensity-controlled carbon ion therapy for mucosal melanoma of the paranasal sinus
Angela Mohr, Naved Chaudhri, Jessica C Hassel, et al.
Oncotarget
|
May 7, 2016
Which melanoma patient carries a BRAF-mutation? A comparison of predictive models
Thomas Eigentler, Zeinab Assi, Jessica C Hassel, et al.
International Journal of Cancer
|
November 21, 2022
Molecular prediction of clinical response to anti-PD-1/anti-PD-L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry-based investigations
Rémi Longuespée, Dirk Theile, Inka Zörnig, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 15, 2023
Can physiologic colonic [<sup>18</sup>F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
Christos Sachpekidis, Christoph K Stein-Thoeringer, Annette Kopp-Schneider, et al.
Trends in Immunology
|
December 28, 2024
Targeting molecular pathways to control immune checkpoint inhibitor toxicities
Robin Reschke, Ryan J Sullivan, Evan J Lipson, et al.
Page
of 33